963
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Short-acting β2-agonist prescription patterns in patients with asthma treated by specialists in Thailand: results from SABINA III

, MDORCID Icon, , MDORCID Icon, , MD, , MSc (Pharm)ORCID Icon & , MDORCID Icon
Pages 2177-2188 | Received 19 Aug 2022, Accepted 20 Jun 2023, Published online: 05 Jul 2023

References

  • Global Asthma Network (GAN). The global asthma report; 2022 [cited 2023 Jan 10]. Available from: http://globalasthmareport.org
  • Boonsawat W, Thompson PJ, Zaeoui U, Samosorn C, Acar G, Faruqi R, Poonnoi P. Survey of asthma management in Thailand – the asthma insight and management study. Asian Pac J Allergy Immunol 2015;33(1):14–20. doi:10.12932/AP0473.33.1.2015.
  • Census and Economic Information Center. Thailand household income per capita; 2017 [cited 2021 Jul 20]. Available from: https://www.ceicdata.com/en/indicator/thailand/annual-household-income-per-capita
  • Dilokthornsakul P, Lee TA, Dhippayom T, Jeanpeerapong N, Chaiyakunapruk N. Comparison of health care utilization and costs for patients with asthma by severity and health insurance in Thailand. Value Health Reg Issues 2016;9:105–111. doi:10.1016/j.vhri.2016.03.001.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2022 [cited 2023 Jan 10]. Available from: http://ginasthma.org
  • O’Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J 2017;50(3):1701103. doi:10.1183/13993003.01103-2017.
  • Aldridge RE, Hancox RJ, Robin Taylor D, Cowan JO, Winn MC, Frampton CM, Town GI. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma. Am J Respir Crit Care Med 2000;161(5):1459–1464. doi:10.1164/ajrccm.161.5.9906052.
  • Nwaru BI, Ekstrom M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J 2020;55(4):1901872. doi:10.1183/13993003.01872-2019.
  • Bloom CI, Cabrera C, Arnetorp S, Coulton K, Nan C, van der Valk RJP, Quint JK. Asthma-related health outcomes associated with short-acting β2-agonist inhaler use: an observational UK study as part of the SABINA global program. Adv Ther 2020;37(10):4190–4208. doi:10.1007/s12325-020-01444-5.
  • FitzGerald JM, Tavakoli H, Lynd LD, Al Efraij K, Sadatsafavi M. The impact of inappropriate use of short acting beta agonists in asthma. Respir Med 2017;131:135–140. doi:10.1016/j.rmed.2017.08.014.
  • Stanford RH, Shah MB, D’Souza AO, Dhamane AD, Schatz M. Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol 2012;109(6):403–407. doi:10.1016/j.anai.2012.08.014.
  • Shlomi D, Katz I, Segel MJ, Oberman B, Peled N. Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase. J Asthma 2018;55(5):571–577. doi:10.1080/02770903.2017.1348513.
  • Shlomi D, Oberman B, Katz I. Short-acting bronchodilators purchase as a marker for asthma control. J Asthma 2022;59(1):206–212. doi:10.1080/02770903.2020.1837157.
  • Thai Asthma Council and Association, The Asthma Association of Thailand. Guidelines for diagnosis and treatment of asthma in Thailand-adult revised edition-2020 [cited 2023 Jan 10]. Available from: https://www.tac.or.th
  • Cabrera CS, Nan C, Lindarck N, Beekman MJHI, Arnetorp S, van der Valk RJP. SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma. Eur Respir J 2020;55(2):1901858. doi:10.1183/13993003.01858-2019.
  • Bateman ED, Price DB, Wang HC, Khattab A, Schonffeldt P, Catanzariti A, van der Valk RJP, Beekman MJHI. Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study. Eur Respir J 2022;59(5):2101402. doi:10.1183/13993003.01402-2021.
  • Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180(1):59–99. doi:10.1164/rccm.200801-060ST.
  • WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3.
  • Khattab A, Madkour A, Ambaram A, Smith C, Muhwa CJ, Mecha JO, Alsayed M, Beekman MJHI. Over-prescription of short-acting β(2)-agonists is associated with poor asthma outcomes: results from the African cohort of the SABINA III study. Curr Med Res Opin 2022;38(11):1983–1995. doi:10.1080/03007995.2022.2100649.
  • Alzaabi A, Al Busaidi N, Pradhan R, Shandy F, Ibrahim N, Ashtar M, et al. Over-prescription of short-acting β(2)-agonists and asthma management in the Gulf region: a multicountry observational study. Asthma Res Pract 2022;8(1):3.
  • Shen S-Y, Chen C-W, Liu T-C, Wang C-Y, Chiu M-H, Chen Y-J, Lan C-C, Shieh J-M, Lin C-M, Wu S-H, et al. SABA prescriptions and asthma management practices in patients treated by specialists in Taiwan: results from the SABINA III study. J Formos Med Assoc 2022;121(12):2527–2537. doi:10.1016/j.jfma.2022.05.014.
  • Yorgancıoğlu A, Aksu K, Naycı SA, Ediger D, Mungan D, Gül U, Beekman MJHI, SABINA Turkey Study Group. Short-acting β(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III. BMC Pulm Med 2022;22(1):216. doi:10.1186/s12890-022-02008-9.
  • Modi M, Mody K, Jhawar P, Sharma L, Padukudru Anand M, Gowda G, Mendiratta M, Kumar S, Nayar S, Manchanda M, et al. Short-acting β2-agonists over-prescription in patients with asthma: an Indian subset analysis of international SABINA III study. J Asthma 2023;60(7):1347–1358. doi:10.1080/02770903.2022.2147079.
  • Suriyawongpaisal P, Aekplakorn W, Leerapan B, Lakha F, Srithamrongsawat S, von Bormann S. Assessing system-based trainings for primary care teams and quality-of-life of patients with multimorbidity in Thailand: patient and provider surveys. BMC Fam Pract 2019;20(1):85. doi:10.1186/s12875-019-0951-6.
  • Tejativaddhana P, Briggs D, Fraser J, Minichiello V, Cruickshank M. Identifying challenges and barriers in the delivery of primary healthcare at the district level: a study in one Thai province. Int J Health Plan Manage 2013;28(1):16–34. doi:10.1002/hpm.2118.
  • WHO Primary Health Care Systems (PRIMASYS). Case study from Thailand; 2017 [cited 2023 Jan 10]. Available from: https://apps.who.int/iris/rest/bitstreams/1344396/retrieve
  • Thanaviratananich S, Cho SH, Ghoshal AG, Muttalif ARBA, Lin HC, Pothirat C, Chuaychoo B, Aeumjaturapat S, Bagga S, Faruqi R, et al. Burden of respiratory disease in Thailand: results from the APBORD observational study. Medicine 2016;95(28):e4090. doi:10.1097/MD.0000000000004090.
  • Boonsawat W, Charoenphan P, Kiatboonsri S, Wongtim S, Viriyachaiyo V, Pothirat C, Thanomsieng N. Survey of asthma control in Thailand. Respirology 2004;9(3):373–378. doi:10.1111/j.1440-1843.2004.00584.x.
  • Boonsawat W, Thepsuthammarat K. Reducing asthma admission: impact of the Easy Asthma Clinic Network. Eur Respir J 2012;40(56 Suppl):4342.
  • Boonsawat W, Sawanyawisuth K. A real-world implementation of asthma clinic: make it easy for asthma with Easy Asthma Clinic. World Allergy Organ J 2022;15(10):100699. doi:10.1016/j.waojou.2022.100699.
  • Aggarwal B, Shantakumar S, Hinds D, Mulgirigama A. Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR): physician beliefs and practices about diagnosis, assessment, and treatment of coexistent disease. J Asthma Allergy 2018;11:293–307. doi:10.2147/JAA.S180657.
  • Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, Busby J, Jackson DJ, Pfeffer PE, Rhee CK, et al. Characterization of severe asthma worldwide: data from the international severe asthma registry. Chest 2020;157(4):790–804. doi:10.1016/j.chest.2019.10.053.
  • Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. JAMA 2018;319(14):1485–1496. doi:10.1001/jama.2018.2769.
  • Price D, Hancock K, Doan J, Taher SW, Muhwa CJ, Farouk H, Beekman MJHI. Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort. NPJ Prim Care Respir Med 2022;32(1):37. doi:10.1038/s41533-022-00295-7.
  • Kitreerawutiwong N, Jordan S, Hughes D. Facility type and primary care performance in sub-district health promotion hospitals in northern Thailand. PLOS One 2017;12(3):e0174055. doi:10.1371/journal.pone.0174055.
  • Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003;124(2):474–481. doi:10.1378/chest.124.2.474.
  • de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLOS One 2013;8(5):e62985. doi:10.1371/journal.pone.0062985.